JOURNAL OF UROLOGY, cilt.175, sa.6, ss.2345-2349, 2006 (SCI-Expanded)
Purpose: We investigated the relationship of adrenergic responses in corpus cavernosum tissues in the presence of BOO using the alpha 1-adrenergic receptor antagonist doxazosin (Pfizer, New York, New York) and the rho-kinase inhibitor Y-27632 (Calbiochem, San Diego, California).